Merck Group’s CVC managing directors Owen Lozman and Hakan Goker speak about the transformational power of machine learning in pharma and materials science.

The founding partner of Zacua Ventures, Juan Nieto, joins the pod to talk about the large returns that are possible from technology adoption in the highly fragmented construction industry.

EnBW New Ventures managing director Crispin Leick talks about why CVCs should focus on financial performance and become limited partners in other funds.

Marty Reid reveals how SETsquared has built an innovation cluster across six universities and becoming a leader in sectors like quantum.

Superconductors have already proven revolutionary in healthcare (they make MRIs possible) but could they help us achieve net zero? Prof Susie Speller says yes.

Nick McNaughton discusses the importance of turning early career researchers into entrepreneurs en masse across the Five Eyes markets.

MSW Capital's Richard Zeiger joins the pod to talk about its multi-corporate LP approach and why it rejects the CVC-as-a-service label.

Tas Gohir discusses how Guy's and St Thomas' is commercialising innovations and tackling NHS challenges like long waitlists.

Owen Thompson, of venture builder Cambridge Future Tech, talks about how researchers need to focus not just on complex technical challenges but on solving real-world problems.